We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.05B
AUM Growth
-$342M
Cap. Flow
-$333M
Cap. Flow %
-8.21%
Top 10 Hldgs %
11.89%
Holding
2,058
New
529
Increased
346
Reduced
400
Closed
620

Sector Composition

Rank Sector Weight
1 Technology 14.25%
2 Healthcare 11.64%
3 Consumer Discretionary 10.2%
4 Industrials 7.56%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETS icon
1326
PetMed Express
PETS
$42.5M
$59.2K ﹤0.01%
+12,282
New +$57.5K
ATMCR
1327
DELISTED
AlphaTime Acquisition Corp Right
ATMCR
$59.2K ﹤0.01%
438,093
HTOO icon
1328
CALL
Fusion Fuel Green
HTOO
$18M
$58.7K ﹤0.01%
2,980
AGL icon
1329
Agilon Health
AGL
$1.58B
$58.4K ﹤0.01%
+1,230
New +$74.4K
IRWD icon
1330
Ironwood Pharmaceuticals
IRWD
$709M
$57.5K ﹤0.01%
+12,970
New +$52.6K
CANG
1331
Cango Inc
CANG
$67.3M
$57.2K ﹤0.01%
+1,300
New +$44.8K
KOPN icon
1332
Kopin
KOPN
$769M
$56.9K ﹤0.01%
41,832
-398,756
-91% -$383K
SGMT icon
1333
Sagimet Biosciences
SGMT
$493M
$56.3K ﹤0.01%
12,518
-102,433
-89% -$519K
DTSQR
1334
DT Cloud Star Acquisition Corp Right
DTSQR
$56.3K ﹤0.01%
+408,079
New +$54.4K
NUVB icon
1335
Nuvation Bio
NUVB
$2.24B
$55.9K ﹤0.01%
21,010
+125
+0.6% +$322
CDIOW icon
1336
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$662K
$55.5K ﹤0.01%
60,540
RDNW
1337
RideNow Group
RDNW
$264M
$54.7K ﹤0.01%
+10,079
New +$55.9K
WTMAR
1338
DELISTED
Welsbach Technology Metals Acquisition Corp. one right to receive 1/10th of a share of common stock
WTMAR
$54.4K ﹤0.01%
621,600
LRMR icon
1339
Larimar Therapeutics
LRMR
$427M
$53.1K ﹤0.01%
13,731
-2
-0% -$13
ATYR
1340
aTyr Pharma
ATYR
$51.9M
$52.7K ﹤0.01%
+14,568
New +$44.1K
QNRX
1341
Quoin Pharmaceuticals
QNRX
$8.74M
$52.5K ﹤0.01%
+2,306
New +$52.9K
WINVR
1342
DELISTED
WinVest Acquisition Corp. Right
WINVR
$52.3K ﹤0.01%
590,000
BDSX icon
1343
Biodesix
BDSX
$236M
$52.2K ﹤0.01%
+1,706
New +$50.2K
EURKR
1344
Eureka Acquisition Corp Right
EURKR
$51.7K ﹤0.01%
258,457
BTE icon
1345
Baytex Energy
BTE
$3B
$50.2K ﹤0.01%
+19,562
New +$55.5K
GAME icon
1346
GameSquare
GAME
$36.6M
$48.8K ﹤0.01%
59,132
LYRA
1347
DELISTED
LYRA THERAPEUTICS INC
LYRA
$48.3K ﹤0.01%
4,680
+27
+0.6% +$297
SVC
1348
Service Properties Trust
SVC
$1.03B
$48K ﹤0.01%
+3,778
New +$61K
KRMD icon
1349
KORU Medical Systems
KRMD
$195M
$47.8K ﹤0.01%
12,424
-253,658
-95% -$824K
EXFY icon
1350
Expensify
EXFY
$186M
$47.8K ﹤0.01%
+14,272
New +$38.4K

Similar funds

Boothbay Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, Boothbay Fund Management held 2,058 positions worth $4.05B, down 7.8% from $4.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Boothbay Fund Management withdrew a net $333M in Q4 2024, closing 620 positions and reducing 400 holdings. Its most notable exit was Nova Vision Acquisition Corp. Warrant, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Cardinal Health worth $10.8M.

  • Boothbay Fund Management's largest Q4 2024 buy was Cardinal Health: 91,430 shares worth $10.8M.
  • Boothbay Fund Management added most to Arthur J. Gallagher & Co in Q4 2024, an estimated $20M increase.
  • Boothbay Fund Management's biggest Q4 2024 reduction was Dell, cutting an estimated $36.8M.
  • Boothbay Fund Management fully exited Nova Vision Acquisition Corp. Warrant in Q4 2024, selling an estimated $18.1M.
  • Boothbay Fund Management's ten largest holdings make up 12% of its $4.05B portfolio in Q4 2024.
  • Boothbay Fund Management opened 529 new positions and closed 620 in Q4 2024.
  • Boothbay Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.05B.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.